SOURCE: Xtalks

Xtalks Webinars

October 07, 2015 07:00 ET

Emerging Trends in Large Molecule Bioanalysis, New Webinar Hosted by Xtalks

TORONTO, ON--(Marketwired - October 07, 2015) - The growth of biopharmaceuticals is increasing rapidly, driven largely by their enormous potential to treat a wide array of human diseases. To keep pace with the expanding field, bioanalytical scientists must continually revisit and reassess new technologies and operational approaches to the bioanalytical characterization of an ever-diversifying class of products.

Join industry experts Andy Vick (Vice President, Analytical Services, WIL Research), Binodh DeSilva (Executive Director, Immunochemistry and Biomarker Development, Bristol-Myer Squibb Company), Valerie Leesch (Associate Scientific Director, WIL Research), Theresa Goletz (Founder, Theresa Goletz Consulting) and Elizabeth Groeber (Director, Bioanalytical Chemistry, WIL Research) for an interactive webinar, on Monday, October 19, 2015 at 10am EDT / 3pm BST (UK/GMT+1).

Today, biotechnology products represent an estimated 24 percent of the world's pharmaceutical sales, and approximately 50 percent of the top 100 products on the market. Biopharma's current annual growth rate of more than 8 percent is double that of conventional pharma, and growth is expected to continue at that rate for the foreseeable future. The growth does not come without challenges, and there is increased demand on the bioanalytical community supporting the development of biopharmaceuticals.

The purpose of this webinar is to provide an educational forum to discuss current issues and applications associated with the analysis of large molecules in biological matrices. The webinar is designed to include and encourage open exchange of scientific and methodological applications for large molecule bioanalysis. Goals and objectives of this webinar include:

  • To provide a better understanding of the role and impact of critical reagents used in ligand binding assays.
  • To provide insight into the interpretation of FDA's Bioanalytical Method Validation guidance document in a practical laboratory setting, with a special focus on matrix stability of protein therapeutics, and on dilutional linearity and parallelism of therapeutics dosed at high concentration in toxicological studies.
  • To gain an understanding on the current state of the art of immunogenicity assessment.
  • To gain insight into analysis of biopharmaceuticals through innovations in mass spectrometry.

To learn more or register for this event visit: Emerging Trends in Large Molecule Bioanalysis

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit: http://xtalks.com

For information about hosting a webinar visit: http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2015/10/6/11G066568/Images/WIL_LOGO_RGB2-637674368888.jpg

Contact Information